Start 30 days free, no card. Full Pro access for a month, then decide. Start free

Back to analysts list

Analyst

Brian Bedell

Deutsche Bank · covers Financial Services

Period: Reporting periods mapped to calendar 2024 Q4 – 2026 Q2 (7 quarters).

Questions
94on tracked calls
Challenge rate
1%1 of 94 questions
Companies
17questioned at least once
Reporting periods
7with questions

These figures cover the whole profile: every tracked question, all reporting periods.

How to read these numbers

Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right.

Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.

No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.

Fewer than 3 questions. A company-level rate is withheld when fewer than 3 questions were recorded for that company; the questions are still counted everywhere else.

Small samples. Profiles with fewer than 10 questions are marked Limited sample.

Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.

Questions asked

Grouped by company, most questions first. Open a company to read its questions, newest reporting period first.

Showing 94 of 94 questions from 17 companies

IVZInvesco14 questions · 7 reporting periods · 0 of 14 challenging
IVZ company page →

Calendar 2026 Q2

Any chance that you can sort of think about when you might turn positive on the equity flows

DemandCompetitive DynamicsTranscript · FY2026 Q2 →
Show response

Schlossberg framed the outflows as non-recurring institutional mandates and tied recovery to market demand for active equities without committing to a timeline.

can you just talk about the variable the overall variable component of the expenses

Cost PressureGuidance ReliabilityTranscript · FY2026 Q2 →
Show response

Dukes redirected from the total expense guide to the comp-to-revenue relationship, explaining the Q1 dollar guide was issued because of the sharp AUM move.

Calendar 2026 Q1

Can you talk about the institutional usage versus the retail usage

Show response

Andrew noted institutional ownership growing globally with UCITS version and Asian market listings. Different price points not possible in ETF format but available through separate accounts. QQQ ecosystem totals approximately $550 billion AUM worldwide.

do you think those ratios that relationship is a good run rate to be modeling for the rest of the year?

Show response

Allison confirmed 22-23% third-party/management fee ratio holds going forward. Q1 had $11M reduction from Intelliflo sale in service and distribution fees. Marketing budget remains $60-100M range, fully in run rate, with significant international allocation.

Calendar 2025 Q4

are you seeing actual traction building here this coming year?

DemandRegulation PolicyTranscript · FY2025 Q4 →
Show response

Andrew noted more traction in U.K. and Europe than U.S. for private markets in DC, viewing it as a multi-geography opportunity that LGT partnership will help address given their institutional market reputation.

I just wanted to clarify if that $3.2 billion is the right number to start with, given the isolated impacts that you mentioned

Cost PressureMarginTranscript · FY2025 Q4 →
Show response

Allison confirmed $3.2B is correct starting point but with QQQ marketing budget ($60-100M range, near midpoint) as a notable addition not present in 2025. Final 2026 expenses expected somewhat above $3.2B but with higher revenue as well.

Calendar 2025 Q3

On the India sale, is there a segmentation of where that $15 billion is coming out of in the categories?

Geographic ExpansionInnovation & R&DTranscript · FY2025 Q3 →
Show response

Allison confirmed India $15 billion comes out of China JV and India category. QQQ conversion would happen effectively the next day after shareholder meeting if quorum and vote are achieved.

is that moving more into the ETF and index bucket? Or should we think about this over the long term as propelling growth in that ETF and index bucket?

Product LaunchInnovation & R&DTranscript · FY2025 Q3 →
Show response

Andrew expects growth across ETF, SMA, and model portfolio wrappers spanning all investment capabilities. Fixed income ETFs have led growth so far, with equity expected to pick up pace.

Calendar 2025 Q2

the licensing expense to NASDAQ and the administrative to Bank of New York. Do those -- just to clarify, do those both go into the third-party distribution and servicing expense line?

Show response

Allison confirmed all 14 bps (NASDAQ licensing + Bank of New York custody + discretionary marketing) go to third-party distribution expense, leaving clean 4 bps net revenue improvement.

Maybe if you can talk about how you view your position there? What is your strategy?

DemandRegulation PolicyTranscript · FY2025 Q2 →
Show response

Andrew noted regulatory and litigation relief needed first, but Invesco has trust company and collective trust wrapper capabilities plus multi-asset expertise to serve DC plans when market develops.

Calendar 2025 Q1

are you seeing any substantial differences within those local regions, given all of the tariff negotiations

Trade TariffsGeographic ExpansionTranscript · FY2025 Q1 →
Show response

Andrew noted markets outside US showing better flow resiliency than US in the short run. Diversity across $550B non-US AUM is a key differentiator.

can you talk a little about the economic participation for Invesco Ltd.?

Show response

Andrew confirmed Invesco is distributor and product operator. Revenue sharing terms not disclosed. Too early to estimate growth potential.

Calendar 2024 Q4

how are you thinking about the active ETF line up? Your ETF business has been growing. How do you think about what to transition to have an active tag along it product

Product LaunchInnovation & R&DTranscript · FY2024 Q4 →
Show response

Andrew outlined multiple paths: conversions, cloning, and potential ETF share classes. Cloning sounds elegant but is not always simplest; core focus remains on high-quality investment results.

just your view on the comps revenue ratio that’s within your 1% guide under flat markets

MarginCost PressureTranscript · FY2024 Q4 →
Show response

Allison noted comp-to-revenue at 43% in 2024, targeting return toward 42% range with strong revenue growth. Longer-term target remains 38-42%.

CMECME Group11 questions · 7 reporting periods · 0 of 11 challenging
CME company page →

Calendar 2026 Q2

what would your view be on any potential down the road CFTC approval of equity perps, particularly S&P?

Competitive DynamicsRegulation PolicyTranscript · FY2026 Q2 →
Show response

Terry addressed all parts: swap classification, no need for a separate clearing entity, S&P index exclusivity, and equity-perp systemic risk.

Calendar 2026 Q1

if you could just talk about the April collateral balances that you're seeing so far

Revenue GrowthMarginTranscript · FY2026 Q1 →
Show response

Lynne disclosed April cash balances up to $153B from $149B Q1 average at steady 33bps. Noncash balances also up slightly to $174B from $171B at 10bps. Both trending positively.

What is your view on potentially creating company KPI types of contracts, like financial KPI contracts

Product LaunchRegulation PolicyTranscript · FY2026 Q1 →
Show response

Tim McCourt said there is customer interest but regulatory clarity is needed on security vs commodity classification. No imminent plans or path forward yet, stay tuned.

Calendar 2025 Q4

Can you talk about conversations that you are having with other distribution partners?

Product LaunchSubscriber GrowthTranscript · FY2025 Q4 →
Show response

Tim McCourt described robust pipeline with 120-130 retail partners working to connect. Terry clarified CME would list larger political contracts and will participate in sports events as long as CFTC deems them legal swaps.

Calendar 2025 Q3

is this cleared in a club fashion? And in the -- with the FCM that you're cooperating here with FanDuel, just to clarify, would this then be open to all other retail platforms

Product LaunchCompetitive DynamicsTranscript · FY2025 Q3 →
Show response

Terry confirmed all FCMs can offer event contracts. Lynne clarified DCM and DCO fees are consistent for all participants. FanDuel FCM is one of many; economics with FanDuel involve non-clearing FCM ownership.

Calendar 2025 Q2

Can you just talk about the recent take-up? You said 90,000 customers -- new traders. How you're measuring that?

Subscriber GrowthProduct LaunchTranscript · FY2025 Q2 →
Show response

Terry noted NCA up 56% is unprecedented. Julie detailed fifth consecutive quarter of double-digit NCA growth, Micro Bitcoin up 94%, Micro Ether up 212%. Tim cited crypto ADV of 190,000 contracts up 130% YoY.

Calendar 2025 Q1

to what extent is this designed for basis trading between treasuries and futures?

Product LaunchCapital AllocationTranscript · FY2025 Q1 →
Show response

Terry denied basis trade was the impetus for BrokerTec Chicago. Lynne noted Aastra contributed $89M in 2024 earnings, typically $20-22M per quarter. Collateral spread 35bp on cash, 10bp on non-cash.

can you comment on to what extent retail users may use other contracts that's outside of micro, like how good of a proxy is micro for retail?

Subscriber GrowthPricingTranscript · FY2025 Q1 →
Show response

Julie and Terry explained retail trades full-size gold and crypto contracts too. Tiering is per-asset-class, intentionally incenting velocity at high-volume periods. Micro gold pricing was increased Feb 1.

Calendar 2024 Q4

can you cite like what portion of your revenue you think is coming from that retail or pro-retail? Or is that too difficult to assess?

Revenue GrowthSubscriber GrowthTranscript · FY2024 Q4 →
Show response

Julie declined to disclose total retail revenue share but reiterated two-thirds of $1 billion NCA revenue over five years comes from retail.

If you can go through the rates coming into 1Q on the cash collateral? And is there -- has there already been any change with the new program coming into this year?

Show response

Lynne provided specific figures: Q4 $75B cash average, Q1 QTD $77B. Non-cash collateral $178B in Q4, $175B QTD. Collateral surcharge doesn't take effect until April.

the simple question is, aren't they all coming in from retail-oriented FCMs, or where is there a mix that you can't tell?

Subscriber GrowthInnovation & R&DTranscript · FY2024 Q4 →
Show response

Terry clarified the blurring is retail vs institutional, not within retail segments. Julie noted non-professional device usage increased almost 40% from Q3 to Q4.

CBOECboe Global Markets7 questions · 6 reporting periods · 0 of 7 challenging
CBOE company page →

Calendar 2026 Q2

just your level of confidence in getting that approved by the end of the third quarter.

Regulation PolicyPricingTranscript · FY2026 Q2 →
Show response

Craig said the SEC process is going smoothly with a comment period ending the following Wednesday; Rob said KPI pricing will align with other event-contract markets. Direct.

Calendar 2026 Q1

How do you envision this industry playing out over the long term and how Cboe would participate in that?

Product LaunchInnovation & R&DTranscript · FY2026 Q1 →
Show response

Craig and Rob gave a detailed view: early-stage but large opportunity, leading with securities-based XSP binary options and exploring KPI contracts.

Calendar 2025 Q4

the second-quarter launch for the just to clarify, that's for the binary options, I believe

Product LaunchRevenue GrowthTranscript · FY2025 Q4 →
Show response

Rob confirmed Q2 launch is all-or-none style intertwined with SPX spreads, starting with index. Traditional event contracts to follow as market adoption grows. Jill confirmed small revenue contribution in 2026 guide, expects ramp over time. Canada/Australia still in revenue guide since still operating.

Calendar 2025 Q3

Maybe just to focus in on the retail strategy and JJ's game plan for -- maybe just sort of expand more on how you might be doing this differently

Product LaunchSubscriber GrowthTranscript · FY2025 Q3 →
Show response

Prashant outlined financial/economic event contracts focus. Rob noted $18B daily SPX premium vs <$50M in prediction markets - opportunity to bring existing liquidity pools. JJ brings 4 decades retail experience.

should we be thinking of the future global footprint for Cboe as largely being U.S. and European centric?

Geographic ExpansionCapital AllocationTranscript · FY2025 Q3 →
Show response

Craig confirmed US/Europe focus for operations. Chris added FX remains global, European equities in 5th straight quarter as top grower. Jill clarified 3% revenue/8-10% expense figures are aggregate across all actions including Japan.

Calendar 2025 Q2

your perspective on how the securities exchange industry has evolved and how you think it might evolve in the future?

Innovation & R&DRegulation PolicyTranscript · FY2025 Q2 →
Show response

Craig said retail is structural not cyclical. Exchange companies have become diverse portfolios. Looking at digitization, tokenization, prediction markets as relevant to the evolving landscape. Wants to ensure Cboe competes.

Calendar 2025 Q1

just trying to get a sense of the conservatism in that considering you know, the potential for organically growing your products

Revenue GrowthGuidance ReliabilityTranscript · FY2025 Q1 →
Show response

Dave acknowledged good ACV growth (47% up, off 18% in 2024) but noted uncertainty in macro setup. Constructive outlook with guides to be updated quarterly.

HOODRobinhood Markets, Inc.7 questions · 7 reporting periods · 0 of 7 challenging
HOOD company page →

Calendar 2026 Q2

in terms of migrating more of the event contracts at Hood now to Roth era such as NFL

Product LaunchCompetitive DynamicsRegulation PolicyTranscript · FY2026 Q2 →
Show response

Vlad deferred on CBOE-style KPI contracts given the securities regime; Shiv confirmed a good portion of event flow should migrate to Rothera.

Calendar 2026 Q1

how are you seeing the customer mix evolve from those new deposits

Subscriber GrowthDemandTranscript · FY2026 Q1 →
Show response

Vlad emphasized the Gold attach rate jump to 40% driving multiproduct adoption. Banking and credit card as daily-use products create engagement beyond trading cycles.

Calendar 2025 Q4

what is your appetite for launching contracts in fundamentals, so things like on KPIs and other earnings metrics

Product LaunchRegulation PolicyTranscript · FY2025 Q4 →
Show response

Vlad confirmed strong interest but noted regulatory ambiguity, some financial KPI contracts could fall under securities-based swaps and SEC jurisdiction. Currently have Tesla deliveries contracts. Shiv confirmed Rothera targeting mid-2026 launch.

Calendar 2025 Q3

how the customer behavior has been forming just in the last 2 months. We've seen a big increase in volume, obviously, in September with the NFL and college games added

Product LaunchDemandTranscript · FY2025 Q3 →
Show response

Vlad confirmed over 1,000 live event contracts with new entertainment and culture categories. Adoption strong from existing traders plus new customers joining specifically for prediction markets. Jason added relatively small portion of customers participating so far, suggesting significant room for growth with UI and discoverability improvements.

Calendar 2025 Q2

I think you mentioned, Vlad, there are at least a couple of businesses now in the $50 million range. If you could just elaborate

Revenue GrowthProduct LaunchTranscript · FY2025 Q2 →
Show response

Jason listed TradePMR, Bitstamp, prediction markets, index options, Gold card, and Legend as businesses scaling toward $100M revenue. Did not provide specific timeline for staking or stock tokens.

Calendar 2025 Q1

can you talk about what you're seeing from active traders coming into the complex and the usage on Legend?

DemandProduct LaunchTranscript · FY2025 Q1 →
Show response

Jason confirmed strong sequential growth in Legend volumes with vast majority incremental. Did not update $50M ARR figure. Vlad outlined futures on Legend and live streaming improvements as roadmap.

Calendar 2024 Q4

How should we think about how that is pacing in terms of a growth rate?

Product LaunchRevenue GrowthTranscript · FY2024 Q4 →
Show response

Jason confirmed strong week-over-week growth rates for all three products and expressed optimism about market share gains. Vlad noted products are compounding on each other.

NDAQNasdaq, Inc.7 questions · 7 reporting periods · 0 of 7 challenging
NDAQ company page →

Calendar 2026 Q2

Just your views on the future of Reg NMS just given the -- with the SEC proposals out

Regulation PolicyCompetitive DynamicsTranscript · FY2026 Q2 →
Show response

Adena gave a detailed view on Reg NMS/order protection rule reform, seeing room to innovate on market models while preserving resiliency and the NBBO.

Calendar 2026 Q1

can you also talk about the potential impact across your fintech platform as the clients increasingly need to respond to always on

Innovation & R&DDemandTranscript · FY2026 Q1 →
Show response

Friedman outlined four demand vectors from always-on transition: surveillance for international hours trading, Eclipse trading platform for markets extending hours, Calypso collateral management across all markets and clearing houses, and trade management services colocation for 23/5 support.

Calendar 2025 Q4

should we think of potentially an acceleration of RegTech and cap markets revenue growth higher towards the higher end of those ranges or at least acceleration on a full-year basis in '26 versus '25

Revenue GrowthSubscriber GrowthTranscript · FY2025 Q4 →
Show response

Friedman declined specific 2026 outlook but emphasized strong pipeline engagement across all FinTech subdivisions globally. Cautioned Q4 is cyclically largest sales quarter. Innovation at scale continuing as core strategy.

Calendar 2025 Q3

Do you see the emergence of your AI solutions helping to advance that faster? And then if you can just remind us where you are currently on that revenue synergy target

Show response

Friedman confirmed 30 cross-sells since Adenza close with 15% pipeline persistence. AI capabilities including GenAI upsells acting as catalyst for cross-sell and upsell activity, giving increased confidence in $100M run rate target by end of 2027.

Calendar 2025 Q2

does this imply you'd be higher within that range given the strength in the second quarter

Revenue GrowthInnovation & R&DTranscript · FY2025 Q2 →
Show response

Friedman maintained general consistency on outlook despite Q2 strength, and confirmed crypto institutionalization was not part of original Adenza thesis but represents upside opportunity.

Calendar 2025 Q1

to what extent your global business and the global nature of Acxiom is maybe potentially offsetting some of those headwinds

Regulation PolicyGeographic ExpansionTranscript · FY2025 Q1 →
Show response

Friedman highlighted global diversification across 100+ regulators, Basel III timing shifts, and crypto as a growth driver for surveillance, Calypso, and Verafin if regulated.

Calendar 2024 Q4

They look very strong in the fourth quarter versus the 2024 trend -- quarterly trends and also versus the third quarter

Revenue GrowthDemandTranscript · FY2024 Q4 →
Show response

Friedman confirmed Q4 is seasonal high for sales but noted strong trends carrying into 2025 with excellent client engagement.

BXBlackstone Inc.6 questions · 6 reporting periods · 0 of 6 challenging
BX company page →

Calendar 2026 Q2

even after a potentially really strong year this year to actually continue to grow into 2027

Revenue GrowthCapital AllocationTranscript · FY2026 Q2 →
Show response

Gray expressed confidence in continued fundraising growth across institutional, insurance, and wealth channels, aided by an eventually more settled rate backdrop.

Calendar 2026 Q1

what you're hearing from financial advisers, and sort of the composition of the clients that are asking for redemption requests

CreditDemandCompetitive DynamicsTranscript · FY2026 Q1 →
Show response

Gray noted redemptions driven by fewer large investors averaging double the typical investor size, same pattern as BREIT. Expects competitive shakeout to benefit BX market share as weaker competitors diminish.

Calendar 2025 Q4

looking at base management fee growth of probably 11%-ish or similar in '26 to '25, again, just because the ramp is happening in the back half. But as we get into '27, does that portend an inflecti...

Revenue GrowthMarginTranscript · FY2025 Q4 →
Show response

Chae confirmed strong multi-year outlook with 2027 benefiting from full-year drawdown fund contributions, infrastructure three-year incentive fee, and operating leverage. Declined to specify FRE margin ceiling.

Calendar 2025 Q3

Are you seeing banks become more competitive in the direct lending business, how is that impacting spreads?

CreditCompetitive DynamicsTranscript · FY2025 Q3 →
Show response

Gray said bank competition is a constant but rising deal volumes help supply-demand balance. Insurance momentum is exceptional with open architecture model as a key differentiator.

Calendar 2025 Q1

do you see any friction in the system as a result of some of the tariff back and forth and maybe if you can comment on that situation in both Europe and Asia

Trade TariffsGeographic ExpansionTranscript · FY2025 Q1 →
Show response

Gray said no material pullback from global clients or private wealth, and BX has benefited from currency strengthening in the U.K., Europe, and yen.

Calendar 2024 Q4

just wondering what your outlook for the FRE margin might be in '25, even just not even considering fee-related performance revenue

MarginRevenue GrowthTranscript · FY2024 Q4 →
Show response

Chae outlined 10% base management fee growth as a starting point, with OpEx growth at 11%, and noted FRPR carries higher incremental margins.

Show 11 more companies
SCHWCharles Schwab Corporation6 questions · 6 reporting periods · 0 of 6 challenging
SCHW company page →

Calendar 2026 Q2

Can you just talk a little bit about the timing of your upcoming launch with Cboe, re the binary index options?

Product LaunchRegulation PolicyTranscript · FY2026 Q2 →
Show response

Working with Cboe on binary options but no timeline; interested in KPI and information markets, but rejects sports-gambling prediction markets.

Calendar 2026 Q1

Any color around -- first on the NNA, we've seen the adviser side grow faster than the retail side

Revenue GrowthDemandTranscript · FY2026 Q1 →
Show response

Wurster highlighted Investor Services reached an all-time monthly NNA high in March, exceeding Advisor Services. Verdeschi attributed cash build to equity market decline, long-short strategies, and strong NNA rather than primarily tax-related.

Calendar 2025 Q4

if the contracts were to develop in more broadly in fundamental investing and other economic types of contracts, is that something you would be interested in launching on the platform?

Innovation & R&DDemandTranscript · FY2025 Q4 →
Show response

Rick distinguished financial prediction markets (open to if demand develops) from sports gambling (explicitly rejected). Noted 95% of current prediction market volume is sports gambling. Active traders prioritizing mobile app, research, and futures/options over prediction markets.

Calendar 2025 Q3

Any color on the revenue and expense components of that? Obviously, things are trending much better than initially expected

MarginGuidance ReliabilityTranscript · FY2025 Q3 →
Show response

Mike confirmed revenue and expense both higher than July scenario, with expenses at or slightly above 5.25%. NIM expected into the 2.80s for Q4. Hedging cut ~1/3 of rate sensitivity.

Calendar 2025 Q2

if you can talk about your confidence in being within that 5% to 7% organic growth band for the full -- on an annualized basis

Revenue GrowthDemandTranscript · FY2025 Q2 →
Show response

Rick expressed high confidence in second half NNA, noting June acceleration post-tax outflows. Highlighted two growth prongs: NNA growth and deepening client relationships.

Calendar 2024 Q4

do you think you can get back to that 5% level at some point this year

Revenue GrowthDemandTranscript · FY2024 Q4 →
Show response

Rick confirmed expectation of progress toward 5-7% range in 2025, up from 4.3% in 2024, while Mike noted account growth as key driver of deposit formation.

BLKBlackRock5 questions · 5 reporting periods · 0 of 5 challenging
BLK company page →

Calendar 2026 Q2

Can you talk a little bit about how you see the democratization of retail investing in Europe

Geographic ExpansionDemandTranscript · FY2026 Q2 →
Show response

Larry described accelerating European ETF adoption, $1.5 trillion AUM, a nationalization trend toward local investing, and dollar-allocation dynamics tied to Fed policy.

Calendar 2026 Q1

As you grow organic base fee growth faster, do you see a better ability to scale that over time?

MarginRevenue GrowthTranscript · FY2026 Q1 →
Show response

Martin noted GIP and HPS were north of 50% FRE margins at acquisition, sees recurring FRE margin trending toward best-in-class private markets names. Fee rate up 0.2bp sequentially driven by international equities and structural growers.

Calendar 2025 Q3

do you envision having this be BlackRock, Inc. centric digital wallets or rather participate in the broader intermediated ecosystem

Innovation & R&DProduct LaunchTranscript · FY2025 Q3 →
Show response

Martin described partnership model with leading exchanges to build model portfolios mixing crypto, tokenized products, and traditional assets in digital wallets. Tokenization can solve settlement system fragmentation, eliminating PDF sub-docs for private markets.

Calendar 2025 Q2

you're continuing to see strong organic growth in the fixed income, iShares franchise

DemandGeographic ExpansionTranscript · FY2025 Q2 →
Show response

Management cited European ETFs at $1 trillion with 40% market share. Europe 5-6 years behind U.S. in ETF adoption, just beginning same growth trajectory. 38 iShares products had over $1 billion of net inflows in the quarter.

Calendar 2024 Q4

talk a little bit about your confidence, clearly, you have a lot of ways to go into the retail on the Alts side

Product LaunchRegulation PolicyTranscript · FY2024 Q4 →
Show response

Martin outlined Partners Group model solution, European LTIF 2.0 evergreen funds, HPS bringing $20B+ wealth assets including HLEND BDC. Identified target date funds and managed models as two best execution channels for retail alts.

BNYBNY Mellon5 questions · 3 reporting periods · 0 of 5 challenging
BNY company page →

Calendar 2025 Q2

Focusing on the cost reduction element as we've, you know, we have another fifty percent to migrate

MarginInnovation & R&DTranscript · FY2025 Q2 →
Show response

CFO reframed as 'running better' not cost-cutting, noting wave one businesses show notably higher maturity. Platform model creates flywheel of momentum with benefits expected for multiple years.

Calendar 2025 Q1

are the efficiencies and the cross-sell and if I can throw AI in there as well, are these contributions exceeding your expectations

Innovation & R&DMarginTranscript · FY2025 Q1 →
Show response

CEO framed benefits as a multi-year arc: short-term Catalyst savings still flowing, platform model payoffs in 2026-27, and AI benefits building through the end of the decade. Gross savings and investment both meaningfully higher than prior years.

Calendar 2024 Q4

to start with net interest revenue and appreciate all the commentary you made, Dermot, on the factors on that

Revenue GrowthMacroeconomicTranscript · FY2024 Q4 →
Show response

CFO guided for roughly flat balances with NIBs expected to moderate from Q4 levels, with continued proactive asset-side management driving the mid-single-digit NII guide.

I think, Dermot, you mentioned -- and maybe I missed this, you said you had a revenue guide

Product LaunchRevenue GrowthTranscript · FY2024 Q4 →
Show response

CFO guided $60-70M incremental Wove revenue for 2025 on top of 2024 base, with 36 clients live and 41 signed contracts demonstrating strong adoption momentum.

does this assume generally flat markets? I guess that would be in line with your uncertainty commentary

Revenue GrowthMacroeconomicTranscript · FY2024 Q4 →
Show response

CFO confirmed neutral market growth assumption and quantified sensitivity at approximately $70M in fees per 5% market move, providing clear framework for modeling.

APOApollo Global Management4 questions · 4 reporting periods · 0 of 4 challenging
APO company page →

Calendar 2026 Q2

Can you talk about what you see as the sort of realistic intermediate to longer-term addressable market

Innovation & R&DRevenue GrowthTranscript · FY2026 Q2 →
Show response

Zelter framed ICE JV trading as early-stage, citing fivefold volume growth and expecting a more meaningful revenue contribution in 2 to 3 years.

Calendar 2025 Q4

what kind of progress you're seeing in the DOL and for planned sponsors in terms of their appetite to adopt alternative products

Regulation PolicySubscriber GrowthTranscript · FY2025 Q4 →
Show response

Rowan confirmed open architecture strategy with more partnerships expected. 401(k) will be north of $1B this year but big volumes await rulemaking/guidance. Moving high-grade credit to daily NAV is the unlock for traditional managers.

Calendar 2025 Q3

are you seeing any near-term traction from plan sponsors in thinking about adding privates to their portfolios?

Regulation PolicySubscriber GrowthTranscript · FY2025 Q3 →
Show response

Rowan said guaranteed lifetime income is the holy grail for deaccumulation. 401(k) crossed a couple of billion in managed account platforms. Administration guidance helpful but awaiting formal ruling for massive take-up.

Calendar 2025 Q2

some perspective on sort of the road map of new initiatives within this since Investor Day and maybe focusing on the trading of private credit

Innovation & R&DRevenue GrowthTranscript · FY2025 Q2 →
Show response

Zelter discussed the flywheel connecting ACS to trading and described how transparency and liquidity expand the pie. Noted broader impact from trading ecosystem expected in 12 to 24 months. SRE rate cut sensitivity deferred to follow-up.

BENFranklin Resources4 questions · 4 reporting periods · 0 of 4 challenging
BEN company page →

Calendar 2026 Q1

could you talk about what market you are targeting and the different product types

Product LaunchRevenue GrowthTranscript · FY2026 Q2 →
Show response

Jenny: two near-term opportunities, Benji stablecoin-to-yield conversion, and tokenized ETFs on exchanges (8 on Kraken, 5 on Ondo). Top 5 exchanges have ~1 billion wallets as new client base. 250 Digital bringing institutional crypto venture capability (launching fall). Traditional distributors lack wallets, limiting near-term adoption. Hockey-stick potential depends on exchange adoption speed.

Calendar 2025 Q3

One is just on your views on credit quality in direct lending

CreditGeographic ExpansionTranscript · FY2025 Q4 →
Show response

Jenny stated economy still very strong, consumer strong. Slight uptick in subprime just returning to normal levels. Fixed income market priced for perfection. Very tiny BSP exposure to one of the high-profile problem credits (appeared to be fraud, not systemic). Apera brings lower middle market direct lending in Europe, not a crowded space. Ability to pivot between credit types is important.

Calendar 2025 Q2

What is your, I guess, desire or your plans to potentially integrate private and public products?

Product LaunchDemandTranscript · FY2025 Q3 →
Show response

Jenny detailed $428B retirement assets, $120B in DC. Target date fund ~$19B (from Putnam). Partnership with Apollo on DC private markets. Empower doing adviser-managed accounts with Morningstar where Franklin participates. DC space highly litigious, awaiting DOL safe harbor. Target dates with private markets models launching first half 2026. $2B in sales pipeline for DC space.

Calendar 2025 Q1

How do you how are you positioned from that dynamic within these regions?

Geographic ExpansionCompetitive DynamicsTranscript · FY2025 Q2 →
Show response

Adam noted $470B sourced from outside US. Shift to non-dollar assets and growth-to-value rotation both play to Franklin strengths. International and global equity products well positioned for diversification trend.

KKRKKR4 questions · 4 reporting periods · 0 of 4 challenging
KKR company page →

Calendar 2025 Q4

Just wanted to get your confidence on that $7 between those components and then a couple of cleanups just on catch-up fees in the fourth quarter and timing for the Arctos close

Guidance ReliabilityMarginTranscript · FY2025 Q4 →
Show response

Rob confirmed Arctos close expected Q2 2026. Catch-up fees $26M. Insurance pivot to alternatives and cash accounting makes TOE metric less relevant than originally discussed. Insurance $1B operating earnings +/- for 2026, plus $350M accrued income not in P&L. Strategic Holdings expects to beat $350M guide.

Calendar 2025 Q3

as you think about expanding the overall ROE past the 20% on the fee side, can you talk about that -- the expansion within the Capital Markets business

Revenue GrowthMarginTranscript · FY2025 Q3 →
Show response

Rob confirmed Page 20 figures are all net of 17.5% comp. GA-related Capital Markets opportunity remains hundreds of millions annually, expected to materialize over next couple of years.

Calendar 2025 Q2

is there anything else unusual in terms of like catch-up fees or anything else?

Revenue GrowthCompetitive DynamicsTranscript · FY2025 Q2 →
Show response

Rob said Americas XIV contributed ~$30M in Q2, some Real Assets catch-up fees. Q3 capital markets expected plus or minus in line with Q2. Scott noted 70-80% of pretax income is durable and repeatable.

Calendar 2025 Q1

do you see any kind of ceiling in that, it was basically the view of investing more

MarginRevenue GrowthTranscript · FY2025 Q1 →
Show response

Rob reiterated mid-60% FRE margin sustainable with no cap, citing revenue growth outpacing headcount and operating complexity. Distribution costs described as highest-ROI expense at KKR.

NTRSNorthern Trust4 questions · 2 reporting periods · 0 of 4 challenging
NTRS company page →

Calendar 2025 Q2

Can you comment about like how that's enhancing the ability for client delivery and relationship management

Cloud & AIInnovation & R&DTranscript · FY2025 Q2 →
Show response

O'Grady detailed three categories: process digitization (trust documents), partner tools (AI-powered knowledge access for advisers), and direct client capabilities. Also discussed segment refinement for the $10M-$100M tier to drive stronger organic growth.

can you strip out the allocation between those 2 segments? And I guess what I'm getting at is, excluding GFO, what do you really see as the current penetration

Product LaunchDemandTranscript · FY2025 Q2 →
Show response

O'Grady noted GFO alternatives penetration is actually lower than core wealth since GFO clients go direct to large managers, but 50 South research brings differentiated access. Vehicles evolving from standard funds to interval and evergreen structures for democratization.

Calendar 2024 Q4

to the extent NII oscillates around that target range, let's say, if it's lower, are you still keeping a target

MarginRevenue GrowthTranscript · FY2024 Q4 →
Show response

O'Grady emphasized expense control as the controllable lever regardless of NII or market-driven revenue variability.

How are you envisioning that over the next year, one to two years in longer-term product

Competitive DynamicsDemandTranscript · FY2024 Q4 →
Show response

O'Grady described closer alignment between NTAM and wealth management, segmenting solutions for GFO vs core wealth vs ultra-high net-worth.

STTState Street Corporation4 questions · 2 reporting periods · 0 of 4 challenging
STT company page →

Calendar 2025 Q2

The housekeeping is just the -- your assumptions on market returns for the second half that underpin the 5% to 7% guide

Guidance ReliabilityMacroeconomicTranscript · FY2025 Q2 →
Show response

Mark noted original assumption was 5% point-to-point / 8% average market levels for the year, currently tracking better. Acknowledged considerable volatility makes projections uncertain.

On the concept of tokenization of equities and ETPs and other assets, how are you thinking about that longer term?

Innovation & R&DRegulation PolicyTranscript · FY2025 Q2 →
Show response

Ron sees tokenization accelerating as regulatory frameworks emerge but slower than optimists expect. Opportunities broad: tokenized deposits, money market funds for collateral, real assets. Key regulatory question is impact on core deposits and banks as monetary policy transmitters. STT positioning as servicer first, bank participant second.

Calendar 2024 Q4

what is the interest of doing any sort of more aggressive deposit raising? How do you think about that?

CreditRevenue GrowthTranscript · FY2024 Q4 →
Show response

Mark confirmed deposit expansion is embedded in outlook and the firm has built the muscle for client deposit engagement over recent years.

what's your view of 401(k) plans, potentially adopting alternative products? Would you be positioned to offer those?

Product LaunchRegulation PolicyTranscript · FY2024 Q4 →
Show response

Ron highlighted STT's DC innovation including annuities in target date funds, but noted plaintiff's bar challenges to alternative adoption. Would need DOL safe harbor rule.

ICEIntercontinental Exchange3 questions · 3 reporting periods · 0 of 3 challenging
ICE company page →

Calendar 2026 Q2

are you looking at consensus expectations for revenue and expenses in your deal accretion analysis?

M&AGuidance ReliabilityRevenue GrowthTranscript · FY2026 Q2 →
Show response

Gardiner confirmed consensus EPS as the accretion base and said revenue synergies are hard to quantify. The management-retention and rearchitecting part of the question went unaddressed.

Calendar 2026 Q1

FIDS overall recurring revenue going up 5%, 6%, 7%, 8% and now 9% on a year-over-year basis the last 5 quarters

Revenue GrowthDemandTranscript · FY2026 Q1 →
Show response

Management expressed incremental confidence in higher-end mid-single-digit FIDS targets, noting data center hall timing may moderate H2 growth.

Calendar 2025 Q3

was that the whole segment? Or was that just for recurring? I know you did mention the seasonality in transaction fees

Guidance ReliabilityCompetitive DynamicsTranscript · FY2025 Q3 →
Show response

Warren clarified flat Q4 guidance was recurring only; transactions have seasonal Q4 softness. MBA forecasting high single-digit loan growth for 2026. Ben said PennyMac departure was unsurprising given prior dispute.

ARESAres Management Corporation2 questions · 2 reporting periods · 1 of 2 challenging
ARES company page →

Calendar 2025 Q3

Do you think there's anything structurally going on in the industry aside from a credit cycle that is creating these fraud events

ChallengingCreditCompetitive DynamicsTranscript · FY2025 Q3 →
Show response

Mike characterized fraud events as possibly coincidental or driven by new entrants taking unfamiliar risks. Noted Ares categorically avoids trade finance. 65% and growing of private credit assets in hands of large incumbents. Data from banks, card companies shows no systemic deterioration.

Calendar 2025 Q2

in terms of time line, I think typically, it takes -- you kind of say it's like 1 to 2 years

Capital AllocationRevenue GrowthTranscript · FY2025 Q2 →
Show response

Mike noted historical dry powder vs deployment has been roughly one-to-one. Current $105B not yet paying fees vs LTM deployment in similar range. Deployment pace suggests closer to 12-month conversion.

TROWT. Rowe Price1 question · 1 reporting period · 0 of 1 challenging
TROW company page →

Calendar 2025 Q2

some updated thoughts, Rob, on this? I know you spoke about this on the first quarter call but we've had some obviously additional information since then

Product LaunchM&ARegulation PolicyTranscript · FY2025 Q2 →
Show response

Rob gave extensive answer on the investment case for privates in DC, noting continued plan sponsor caution on fees and fiduciary risk. Waiting on DOL/SEC guidance.

Challenge rate by company

Every company this analyst questioned, most questions first. A company-level rate is shown from 3 questions; below that it is withheld.

CompanyQuestionsChallenge rate
IVZ Invesco140%none of 14 questions
CME CME Group110%none of 11 questions
CBOE Cboe Global Markets70%none of 7 questions
HOOD Robinhood Markets, Inc.70%none of 7 questions
NDAQ Nasdaq, Inc.70%none of 7 questions
BX Blackstone Inc.60%none of 6 questions
SCHW Charles Schwab Corporation60%none of 6 questions
BLK BlackRock50%none of 5 questions
BNY BNY Mellon50%none of 5 questions
APO Apollo Global Management40%none of 4 questions
  • IVZ
    Invesco · 14 questions
    0%none of 14 questions
  • CME
    CME Group · 11 questions
    0%none of 11 questions
  • CBOE
    Cboe Global Markets · 7 questions
    0%none of 7 questions
  • HOOD
    Robinhood Markets, Inc. · 7 questions
    0%none of 7 questions
  • NDAQ
    Nasdaq, Inc. · 7 questions
    0%none of 7 questions
  • BX
    Blackstone Inc. · 6 questions
    0%none of 6 questions
  • SCHW
    Charles Schwab Corporation · 6 questions
    0%none of 6 questions
  • BLK
    BlackRock · 5 questions
    0%none of 5 questions
  • BNY
    BNY Mellon · 5 questions
    0%none of 5 questions
  • APO
    Apollo Global Management · 4 questions
    0%none of 4 questions
Show all 17 companies
CompanyQuestionsChallenge rate
BEN Franklin Resources40%none of 4 questions
KKR KKR40%none of 4 questions
NTRS Northern Trust40%none of 4 questions
STT State Street Corporation40%none of 4 questions
ICE Intercontinental Exchange30%none of 3 questions
ARES Ares Management Corporation2—Rate withheld: fewer than 3 questions
TROW T. Rowe Price1—Rate withheld: fewer than 3 questions
  • BEN
    Franklin Resources · 4 questions
    0%none of 4 questions
  • KKR
    KKR · 4 questions
    0%none of 4 questions
  • NTRS
    Northern Trust · 4 questions
    0%none of 4 questions
  • STT
    State Street Corporation · 4 questions
    0%none of 4 questions
  • ICE
    Intercontinental Exchange · 3 questions
    0%none of 3 questions
  • ARES
    Ares Management Corporation · 2 questions
    —rate withheld: under 3 questions
  • TROW
    T. Rowe Price · 1 question
    —rate withheld: under 3 questions

Activity by reporting period

Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.

Questions by calendar reporting period
Calendar periodQuestionsChallenge rateCompanies
2024 Q4170%none of 17 questions10
2025 Q1110%none of 11 questions9
2025 Q2180%none of 18 questions15
2025 Q3157%1 of 15 questions13
2025 Q4100%none of 10 questions9
2026 Q1120%none of 12 questions10
2026 Q2110%none of 11 questions10
  1. 2024 Q417 questions · challenge rate 0% (none of 17 questions) · 10 companies
  2. 2025 Q111 questions · challenge rate 0% (none of 11 questions) · 9 companies
  3. 2025 Q218 questions · challenge rate 0% (none of 18 questions) · 15 companies
  4. 2025 Q315 questions · challenge rate 7% (1 of 15 questions) · 13 companies
  5. 2025 Q410 questions · challenge rate 0% (none of 10 questions) · 9 companies
  6. 2026 Q112 questions · challenge rate 0% (none of 12 questions) · 10 companies
  7. 2026 Q211 questions · challenge rate 0% (none of 11 questions) · 10 companies

Topics

Topics tagged on this analyst’s questions.

  • Revenue Growth30
  • Product Launch25
  • Demand21
  • Regulation Policy17
  • Innovation & R&D16
  • Margin15
  • Competitive Dynamics12
  • Subscriber Growth10
  • Geographic Expansion9
  • Guidance Reliability7
Show all 18 topics
  • Pricing6
  • Credit5
  • Capital Allocation4
  • M&A4
  • Cost Pressure3
  • Macroeconomic3
  • Cloud & AI2
  • Trade Tariffs2